Cargando…

Influence of Exposure History on the Immunology and Development of Resistance to Human Schistosomiasis Mansoni

BACKGROUND: Previous studies suggest that humans can acquire immunity to reinfection with schistosomes, most probably due to immunologic mechanisms acquired after exposure to dying schistosome worms. METHODOLOGY/PRINCIPAL FINDINGS: We followed longitudinally two cohorts of adult males occupationally...

Descripción completa

Detalles Bibliográficos
Autores principales:	Black, Carla L., Mwinzi, Pauline N. M., Muok, Erick M. O., Abudho, Bernard, Fitzsimmons, Colin M., Dunne, David W., Karanja, Diana M. S., Secor, W. Evan, Colley, Daniel G.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843635/ https://www.ncbi.nlm.nih.gov/pubmed/20351784 http://dx.doi.org/10.1371/journal.pntd.0000637

Ejemplares similares

Association of the Gene Polymorphisms IFN-γ +874, IL-13 −1055 and IL-4 −590 with Patterns of Reinfection with Schistosoma mansoni
por: Gatlin, Michael R., et al.
Publicado: (2009)

Use of Geospatial Modeling to Predict Schistosoma mansoni Prevalence in Nyanza Province, Kenya
por: Woodhall, Dana M., et al.
Publicado: (2013)

Evaluation of Urine CCA Assays for Detection of Schistosoma mansoni Infection in Western Kenya
por: Shane, Hillary L., et al.
Publicado: (2011)

Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections
por: Karanja, Diana M. S., et al.
Publicado: (2017)

Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya – a pilot study
por: Mwinzi, Pauline NM, et al.
Publicado: (2012)

Immunology of human schistosomiasis
por: Colley, D G, et al.
Publicado: (2014)

Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study
por: Abudho, Bernard O., et al.
Publicado: (2018)

A Schistosomiasis Research Agenda
por: Colley, Daniel G., et al.
Publicado: (2007)

Effect of four rounds of annual school‐wide mass praziquantel treatment for schistosoma mansoni control on schistosome‐specific immune responses
por: Ndombi, E. M., et al.
Publicado: (2018)

Impact of Mothers’ Schistosomiasis Status During Gestation on Children’s IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya
por: Ondigo, Bartholomew N., et al.
Publicado: (2018)

When Should the Emphasis on Schistosomiasis Control Move to Elimination?
por: Secor, W. Evan, et al.
Publicado: (2018)

Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial Schistosoma mansoni Infection Prevalence: A Cluster Randomized Trial
por: Secor, W. Evan, et al.
Publicado: (2020)

High prevalence of schistosomiasis in Mbita and its adjacent islands of Lake Victoria, western Kenya
por: Odiere, Maurice R, et al.
Publicado: (2012)

Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya
por: Onkanga, Isaac O., et al.
Publicado: (2016)

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel
por: Kittur, Nupur, et al.
Publicado: (2019)

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya
por: Ondigo, Bartholomew N., et al.
Publicado: (2018)

Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
por: Melman, Sandra D., et al.
Publicado: (2009)

A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population
por: Ogola, George O, et al.
Publicado: (2014)

Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya
por: Abudho, Bernard O., et al.
Publicado: (2020)

A Persistent Hotspot of Schistosoma mansoni Infection in a Five-Year Randomized Trial of Praziquantel Preventative Chemotherapy Strategies
por: Wiegand, Ryan E, et al.
Publicado: (2017)

Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period—Kenya, 2010–2015
por: Sircar, Anita D., et al.
Publicado: (2018)

Idiotypes Expressed Early in Experimental Schistosoma mansoni Infections Predict Clinical Outcomes of Chronic Disease
por: Montesano, M. Angela, et al.
Publicado: (2002)

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni–Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and Tanzania
por: Shen, Ye, et al.
Publicado: (2019)

Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni
por: Pereira, Thiago Almeida, et al.
Publicado: (2016)

Neonatal Idiotypic Exposure Alters Subsequent Cytokine, Pathology, and Survival Patterns in Experimental Schistosoma mansoni Infections
por: Angela Montesano, M., et al.
Publicado: (1999)

La Schistosomiasis Mansoni en Venezuela
por: Tager, M.
Publicado: (1943)

Young Adults in Endemic Areas: An Untreated Group in Need of School-Based Preventive Chemotherapy for Schistosomiasis Control and Elimination
por: Korir, Harrison K., et al.
Publicado: (2018)

Additional Evaluation of the Point-of-Contact Circulating Cathodic Antigen Assay for Schistosoma mansoni Infection
por: Mwinzi, Pauline N. M., et al.
Publicado: (2015)

Malacological survey and geographical distribution of vector snails for schistosomiasis within informal settlements of Kisumu City, western Kenya
por: Opisa, Selpha, et al.
Publicado: (2011)

Early lessons from schistosomiasis mass drug administration programs
por: Secor, W. Evan
Publicado: (2015)

Comparative biochemical analysis of three members of the Schistosoma mansoni TAL family: Differences in ion and drug binding properties
por: Thomas, Charlotte M., et al.
Publicado: (2015)

Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs
por: Secor, W. Evan
Publicado: (2019)

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020)

Change in children’s school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2)
por: Musuva, Rosemary, et al.
Publicado: (2017)

Schistosomiasis Mansoni Manifesting as Multiple Colonic Polyps
por: Akhtar, Muhammed M, et al.
Publicado: (2020)

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries
por: Ezeamama, Amara E., et al.
Publicado: (2016)

Aberrant plasma MMP and TIMP dynamics in Schistosoma - Immune reconstitution inflammatory syndrome (IRIS)
por: Goovaerts, Odin, et al.
Publicado: (2018)

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
por: King, Charles H., et al.
Publicado: (2020)

Pseudotumoral form of cerebral Schistosomiasis Mansoni
por: Romero, FR, et al.
Publicado: (2012)

Decline in transmission of schistosomiasis mansoni in Oman
por: Al Abaidani, Idris, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qfs9fur9qium50f8ecervtefga